Blockchain Registration Transaction Record

VolitionRx's New Blood Test Detects Feline Cancer with 100% Specificity

VolitionRx announces a blood test with 100% specificity for detecting feline lymphoma, aiming to be the first affordable liquid biopsy for cat cancer. Learn about this veterinary breakthrough.

This news matters because it represents a significant advancement in veterinary medicine, offering a non-invasive, affordable solution for early detection of lymphoma in cats, which could lead to earlier treatment and improved survival rates. For pet owners, it means less stress and lower costs compared to traditional diagnostic methods like biopsies, while veterinarians gain a reliable tool to enhance care. In the broader context, it showcases the potential of epigenetics and liquid biopsy technology to transform cancer screening across species, potentially paving the way for similar innovations in human healthcare.